Partnering

We bring technical depth, proven regulatory success, and formulation agility to every partnership.

Commercialization
- Flex Pharma seeks partners for the successful commercialization of its fully-developed pharmaceutical products.
- This includes collaboration on market access strategies, sales, and distribution to bring innovative treatments to patients.
Co-Development
- Flex Pharma is open to co-development partnerships to leverage its proprietary ElectroNanoSpray™ (ENS) technology and formulation expertise.
- This involves collaborating with other pharmaceutical companies to jointly develop new drug products or enhance existing ones.
New Chemical Entities
- Flex Pharma is interested in partnering to apply its ENS technology to New Chemical Entities (NCEs)
- This focuses on working with partners who have novel drug candidates but face challenges with formulation, delivery, or bioavailability.

We bring technical depth, proven regulatory success, and formulation agility to every partnership.